A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia

International Journal of Dermatology

Volumn 52, Issue 1, 2013, Pages 102-105

  Ng, Lim Chui ^a   Lee, Yin Yin ^a   Lee, Chew Kek ^a   Wong, Su ming ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; LIVER ENZYME; METHOTREXATE;

ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DEMOGRAPHY; DERMATOLOGY; DISEASE SEVERITY; FEMALE; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PSORIASIS; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; DERMATOLOGIC AGENTS; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; LIVER; MALAYSIA; MALE; METHOTREXATE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; TIME FACTORS; YOUNG ADULT;

EID: 84871688281     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05436.x     Document Type: Article

References (10)

1. Chang CC, Gangaram HB, Hussein SH. Malaysian Psoriasis Registry- Preliminary report of a pilot study using a newly revised registry form. Med J Malaysia 2008; 63: 68-71.
2. Kuijpers AL, van de Kerkhof PC. Risk-benefit assessment of methotrexate in the treatment of severe psoriasis. Am J Clin Dermatol 2000; 1: 27-39.
3. Roenigk HH Jr, Maibach HI, Weinstein GD. Guidelines on methotrexate therapy for psoriasis. Arch Dermatol 1972; 105: 363-365.
4. Roenigk HH Jr, Auerbach R, Maibach H, et al. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol 1998; 38: 478-485.
5. Chakravarty K, McDonald H, Pullar T, et al. BSR & BHPR guideline for disease-modifying anti-rheumatic drug therapy (DMARD) in consultation with the British Association of Dermatologists. Rheumatology 2008; 47: 924-925.
6. Chong YT, Tey KE, Choon SE. Local experience on the use of Methotrexate in the treatment of Psoriasis in Hospital Sultanah Aminah, Johor Bahru. Malaysian J Dermatol 2010; 25: 1-6.
7. Warren RB, Smith RL, Campalani E, et al. Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms. Br J Dermatol 2009; 160: 438-441.
8. Yazici Y, Erkan D, Paget SA. Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?J Rheumatol 2002; 29: 1586-1589.
9. Heydendael VMR, Spuls PI, Opmeer BC, et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003; 349: 658-665.
10. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99: 1160-1174.